Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2

Akihiko Nishikimi, Takehito Uruno, Xuefeng Duan, Qinhong Cao, Yuji Okamura, Takashi Saitoh, Nae Saito, Shunsuke Sakaoka, Yao Du, Atsushi Suenaga, Mutsuko Kukimoto-Niino, Kei Miyano, Kazuhito Gotoh, Takayoshi Okabe, Fumiyuki Sanematsu, Yoshihiko Tanaka, Hideki Sumimoto, Teruki Honma, Shigeyuki Yokoyama, Tetsuo NaganoDaisuke Kohda, Motomu Kanai, Yoshinori Fukui

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Tissue infiltration of activated lymphocytes is a hallmark of transplant rejection and organ-specific autoimmune diseases. Migration and activation of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain Dbl homology domain typically found in guanine nucleotide exchange factors, DOCK2 mediates the GTP-GDP exchange reaction for Rac through its DHR-2 domain. Here, we have identified 4-[3′-(2″-chlorophenyl)-2′-propen-1′-ylidene] -1-phenyl-3,5-pyrazolidinedione (CPYPP) as a small-molecule inhibitor of DOCK2. CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation. These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.

Original languageEnglish
Pages (from-to)488-497
Number of pages10
JournalChemistry and Biology
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 20 2012

Fingerprint

PDZ Domains
Lymphocytes
Chemical activation
Guanine Nucleotide Exchange Factors
Antigen Receptors
Molecules
Chemokine Receptors
Graft Rejection
Immunosuppressive Agents
Lymphocyte Activation
Guanosine Triphosphate
Autoimmune Diseases
Transplants
T-cells
T-Lymphocytes
Infiltration
Scaffolds
Catalyst activity
Tissue
4-(3'-(2'-chlorophenyl)-2'-propen-1'-ylidene)-1-phenyl-3,5-pyrazolidinedione

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2. / Nishikimi, Akihiko; Uruno, Takehito; Duan, Xuefeng; Cao, Qinhong; Okamura, Yuji; Saitoh, Takashi; Saito, Nae; Sakaoka, Shunsuke; Du, Yao; Suenaga, Atsushi; Kukimoto-Niino, Mutsuko; Miyano, Kei; Gotoh, Kazuhito; Okabe, Takayoshi; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Sumimoto, Hideki; Honma, Teruki; Yokoyama, Shigeyuki; Nagano, Tetsuo; Kohda, Daisuke; Kanai, Motomu; Fukui, Yoshinori.

In: Chemistry and Biology, Vol. 19, No. 4, 20.04.2012, p. 488-497.

Research output: Contribution to journalArticle

Nishikimi, A, Uruno, T, Duan, X, Cao, Q, Okamura, Y, Saitoh, T, Saito, N, Sakaoka, S, Du, Y, Suenaga, A, Kukimoto-Niino, M, Miyano, K, Gotoh, K, Okabe, T, Sanematsu, F, Tanaka, Y, Sumimoto, H, Honma, T, Yokoyama, S, Nagano, T, Kohda, D, Kanai, M & Fukui, Y 2012, 'Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2', Chemistry and Biology, vol. 19, no. 4, pp. 488-497. https://doi.org/10.1016/j.chembiol.2012.03.008
Nishikimi, Akihiko ; Uruno, Takehito ; Duan, Xuefeng ; Cao, Qinhong ; Okamura, Yuji ; Saitoh, Takashi ; Saito, Nae ; Sakaoka, Shunsuke ; Du, Yao ; Suenaga, Atsushi ; Kukimoto-Niino, Mutsuko ; Miyano, Kei ; Gotoh, Kazuhito ; Okabe, Takayoshi ; Sanematsu, Fumiyuki ; Tanaka, Yoshihiko ; Sumimoto, Hideki ; Honma, Teruki ; Yokoyama, Shigeyuki ; Nagano, Tetsuo ; Kohda, Daisuke ; Kanai, Motomu ; Fukui, Yoshinori. / Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2. In: Chemistry and Biology. 2012 ; Vol. 19, No. 4. pp. 488-497.
@article{08bd212c8a414f929ce8ea8b6c276410,
title = "Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2",
abstract = "Tissue infiltration of activated lymphocytes is a hallmark of transplant rejection and organ-specific autoimmune diseases. Migration and activation of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain Dbl homology domain typically found in guanine nucleotide exchange factors, DOCK2 mediates the GTP-GDP exchange reaction for Rac through its DHR-2 domain. Here, we have identified 4-[3′-(2″-chlorophenyl)-2′-propen-1′-ylidene] -1-phenyl-3,5-pyrazolidinedione (CPYPP) as a small-molecule inhibitor of DOCK2. CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation. These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.",
author = "Akihiko Nishikimi and Takehito Uruno and Xuefeng Duan and Qinhong Cao and Yuji Okamura and Takashi Saitoh and Nae Saito and Shunsuke Sakaoka and Yao Du and Atsushi Suenaga and Mutsuko Kukimoto-Niino and Kei Miyano and Kazuhito Gotoh and Takayoshi Okabe and Fumiyuki Sanematsu and Yoshihiko Tanaka and Hideki Sumimoto and Teruki Honma and Shigeyuki Yokoyama and Tetsuo Nagano and Daisuke Kohda and Motomu Kanai and Yoshinori Fukui",
year = "2012",
month = "4",
day = "20",
doi = "10.1016/j.chembiol.2012.03.008",
language = "English",
volume = "19",
pages = "488--497",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2

AU - Nishikimi, Akihiko

AU - Uruno, Takehito

AU - Duan, Xuefeng

AU - Cao, Qinhong

AU - Okamura, Yuji

AU - Saitoh, Takashi

AU - Saito, Nae

AU - Sakaoka, Shunsuke

AU - Du, Yao

AU - Suenaga, Atsushi

AU - Kukimoto-Niino, Mutsuko

AU - Miyano, Kei

AU - Gotoh, Kazuhito

AU - Okabe, Takayoshi

AU - Sanematsu, Fumiyuki

AU - Tanaka, Yoshihiko

AU - Sumimoto, Hideki

AU - Honma, Teruki

AU - Yokoyama, Shigeyuki

AU - Nagano, Tetsuo

AU - Kohda, Daisuke

AU - Kanai, Motomu

AU - Fukui, Yoshinori

PY - 2012/4/20

Y1 - 2012/4/20

N2 - Tissue infiltration of activated lymphocytes is a hallmark of transplant rejection and organ-specific autoimmune diseases. Migration and activation of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain Dbl homology domain typically found in guanine nucleotide exchange factors, DOCK2 mediates the GTP-GDP exchange reaction for Rac through its DHR-2 domain. Here, we have identified 4-[3′-(2″-chlorophenyl)-2′-propen-1′-ylidene] -1-phenyl-3,5-pyrazolidinedione (CPYPP) as a small-molecule inhibitor of DOCK2. CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation. These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.

AB - Tissue infiltration of activated lymphocytes is a hallmark of transplant rejection and organ-specific autoimmune diseases. Migration and activation of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain Dbl homology domain typically found in guanine nucleotide exchange factors, DOCK2 mediates the GTP-GDP exchange reaction for Rac through its DHR-2 domain. Here, we have identified 4-[3′-(2″-chlorophenyl)-2′-propen-1′-ylidene] -1-phenyl-3,5-pyrazolidinedione (CPYPP) as a small-molecule inhibitor of DOCK2. CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation. These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.

UR - http://www.scopus.com/inward/record.url?scp=84860110971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860110971&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2012.03.008

DO - 10.1016/j.chembiol.2012.03.008

M3 - Article

C2 - 22520755

AN - SCOPUS:84860110971

VL - 19

SP - 488

EP - 497

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 4

ER -